INTERNATIONAL SOCIETY FOR NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (EIN 631284546) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2001

Legal Domicile

Principal Officer

KATHERINE SELEY-RADTKE

Phone

4104558684

Tax Period

2025-01-01 to 2025-12-31

INTERNATIONAL SOCIETY FOR NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, founded in 2001, is a micro nonprofit in the Science & Technology sector that reported $78K in total revenue in fiscal year 2025. The organization ran a surplus of $73K, a strong 94% operating margin.

Mission

TO CAPITALIZE ON THE KNOWLEDGE OF PRACTICING MEMBERS ACROSS SEVERAL DISCIPLINES TO UNDERSTAND THE IMPACT OF NUCLEIC ACIDS IN A PLETHORA OF CUTTING-EDGE SCIENTIFIC QUESTIONS RANGING FROM THE ORIGINS OF LIFE TO THE DEVELOPMENT OF NOVEL THERAPEUTICS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $61,091

Program Service Revenue $0

Investment Income $16,445

Other Revenue $0

TOTAL REVENUE $77,536

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $3,074

Other Expenses $4,830

TOTAL EXPENSES $4,830

Year-over-Year Comparison

	2025	2024	Change
Revenue	$77,536	$73,673	+0.1%
Expenses	$4,830	$75,149	-0.9%
Net Income	$72,706	$-1,476	-50.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RAMON ERITJA	PRESIDENT AND CHAIR	5.00	Officer Director	$0	$0	$0
JEAN-JACQUES VASSEUR	IMMEDIATE PAST PRESIDENT	5.00	Director	$0	$0	$0
AMANDA BRYANT-FRIEDRICH	VICE-PRESIDENT	5.00	Officer Director	$0	$0	$0
SUZANNE PEYROTTES	TREASURER	5.00	Officer Director	$0	$0	$0
KATHERINE SELEY-RADTKE	SECRETARY / PAST PRESIDENT	5.00	Officer Director	$0	$0	$0
PROF DR PIET HERDEWIJN	PAST PRESIDENT	5.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$77,536	$4,830	$509,896	$72,706

INTERNATIONAL SOCIETY FOR NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS